Drugs that contain Fospropofol Disodium
1. Lusedra patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US6872838 | EISAI INC | Water soluble prodrugs of hindered alcohols |
Aug, 2018
(5 years ago) | |
| US6204257 | EISAI INC | Water soluble prodrugs of hindered alcohols |
Jul, 2022
(1 year, 9 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Dec 12, 2013 |
NCE-1 date: 12 December, 2012
Market Authorisation Date: 12 December, 2008
Treatment: Sedative-hypnotic agent indicated for monitored anesthesia care (mac) sedation
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
LUSEDRA family patents
